Leonard S. Schleifer
2012
In 2012, Leonard S. Schleifer earned a total compensation of $30M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 184% increase compared to previous year.
Compensation breakdown
| Bonus | $2,300,000 |
|---|---|
| Option Awards | $26,630,306 |
| Salary | $1,000,000 |
| Other | $116,791 |
| Total | $30,047,097 |
Schleifer received $26.6M in option awards, accounting for 88.63% of the total pay in 2012.
Schleifer also received $2.3M in bonus, $1M in salary and $116.8K in other compensation.
Rankings
In 2012, Leonard S. Schleifer's compensation ranked 38th out of 11,487 executives tracked by ExecPay. In other words, Schleifer earned more than 99.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 38 out of 11,487 | 100th |
Division Manufacturing | 16 out of 4,251 | 100th |
Major group Chemicals And Allied Products | 3 out of 1,186 | 100th |
Industry group Drugs | 3 out of 905 | 100th |
Industry Pharmaceutical Preparations | 2 out of 684 | 100th |
Source: SEC filing on April 21, 2015.
Schleifer's colleagues
We found four more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2012.
2012
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2012
Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
2012
Murray Goldberg
Regeneron Pharmaceuticals
Chief Financial Officer
2012
Robert Terifay
Regeneron Pharmaceuticals